At the completion of this CPD activity, optometrists will have developed their knowledge of the patient journey following referral for inherited retinal diseases (IRDs). Including: The four steps of assessment and management of patients with, or suspected of having, IRDs Investigations assisting diagnosis of IRDs and determining visual function An understanding of the genetic workforce and their role in the diagnosis, management, treatment and counselling of patients with IRDs IRD patient management protocols NOTE: Optomery Australia members can enter their details at the bottom of this article to have it automatically added to their Learning Plan. Read More
The vitreoretinal surgeon who performed Australia’s first Luxturna gene therapy has described the intricacy of the procedure, while hailing the team effort that has resulted in profound vision improvements for patients, including one who reported seeing stars for the first time. Read More
Teenage siblings from Sydney with an inherited retinal disease have become the first in Australia to receive the Luxturna ocular gene therapy. Those involved with delivering the novel treatment say it has rescued their vision, with hopes it will prevent them from going blind.